SECuRE trial update: First patient treated in the Phase II Cohort Expansion
- Written by PR Newswire
 |
HIGHLIGHTS
- The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of 67Cu-SAR-bisPSMA.This follows the recent recommendation by the Safety Review Committee (SRC) after the successful completion of the Dose Escalation Phase to commence enrollment for...
